retatrutide clinical trial duration Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP Retatrutide UK: 2026 Clinical Trial

2 Hims & Hers has been one of the most prominent players in the direct-to-consumer GLP-1 space, yet the company has faced its own headwinds in recent months after being required to pull access to compounded semaglutide following FDA action against mass compounding of GLP-1 drugs

Gastroenterology, 165 (5), 12061218

For instance, Wegovy (specifically approved for weight management) has demonstrated impressive results in clinical trials, with many patients losing substantial percentages of their body weight

Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis